| Medical and Health Sciences | Lifetime | 446 | US 243 | 99.98 |
| Pathology and Forensic Medicine | Lifetime | 27 | US 15 | 99.89 |
| Medical Genetics | Lifetime | 51 | US 32 | 99.61 |
| Oncology | Lifetime | 220 | US 120 | 99.65 |
| Hematology | Lifetime | 112 | US 67 | 99.29 |
| Dermatology | Lifetime | 195 | US 78 | 98.73 |
| Clinical Neurology | Lifetime | 550 | US 242 | 97.54 |
| Rheumatology | Lifetime | 606 | US 278 | 97.09 |
| Immunology | Lifetime | 865 | US 440 | 97.13 |
| Cancer Research | Lifetime | 573 | US 302 | 96.28 |
| Pathology and Forensic Medicine | 2021-2025 | 58 | US 22 | 98.76 |
| Medical Genetics | 2021-2025 | 118 | US 47 | 95.48 |
| Hematology | 2021-2025 | 147 | US 68 | 95.87 |
| Oncology | 2021-2025 | 627 | US 279 | 90.63 |
| Immunology | 2021-2025 | 940 | US 353 | 61.93 |
| Cancer Research | 2021-2025 | 462 | US 186 | 59.88 |
| Viral-associated cancers and disorders | Lifetime | 4 | US 2 | 99.85 |
| Lymphoma Diagnosis and Treatment | Lifetime | 11 | US 6 | 99.91 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 30 | US 21 | 99.87 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 7 | US 3 | 99.75 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 7 | US 4 | 99.77 |
| Acute Myeloid Leukemia Research | Lifetime | 72 | US 45 | 99.73 |
| Eosinophilic Disorders and Syndromes | Lifetime | 34 | US 20 | 99.58 |
| T-cell and Retrovirus Studies | Lifetime | 36 | US 19 | 99.26 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 120 | US 57 | 99.25 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 105 | US 61 | 99.40 |
| Sarcoma Diagnosis and Treatment | Lifetime | 224 | US 119 | 98.99 |
| Histiocytic Disorders and Treatments | Lifetime | 29 | US 17 | 98.96 |
| Vascular Tumors and Angiosarcomas | Lifetime | 60 | US 27 | 99.08 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 115 | US 58 | 99.00 |
| Cancer Genomics and Diagnostics | Lifetime | 474 | US 272 | 99.11 |
| Hematological disorders and diagnostics | Lifetime | 89 | US 49 | 98.47 |
| Acute Lymphoblastic Leukemia research | Lifetime | 259 | US 139 | 98.96 |
| Immune Cell Function and Interaction | Lifetime | 883 | US 435 | 98.90 |
| CAR-T cell therapy research | Lifetime | 468 | US 283 | 98.64 |
| Multiple Myeloma Research and Treatments | Lifetime | 290 | US 143 | 98.28 |
| Adrenal and Paraganglionic Tumors | Lifetime | 207 | US 78 | 98.12 |
| Lymphadenopathy Diagnosis and Analysis | Lifetime | 7 | US 2 | 95.97 |
| Parvovirus B19 Infection Studies | Lifetime | 229 | US 117 | 97.35 |
| Cancer-related Molecular Pathways | Lifetime | 838 | US 430 | 97.30 |
| Renal and related cancers | Lifetime | 657 | US 326 | 97.09 |
| Renal cell carcinoma treatment | Lifetime | 723 | US 373 | 97.17 |
| Retinoids in leukemia and cellular processes | Lifetime | 432 | US 229 | 96.44 |
| Genetic factors in colorectal cancer | Lifetime | 967 | US 401 | 97.00 |
| Tumors and Oncological Cases | Lifetime | 446 | US 253 | 96.19 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 154 | US 43 | 94.83 |
| Breast Implant and Reconstruction | Lifetime | 421 | US 241 | 95.40 |
| Salivary Gland Tumors Diagnosis and Treatment | Lifetime | 968 | US 397 | 94.87 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 956 | US 503 | 93.52 |
| Blood disorders and treatments | Lifetime | 954 | US 370 | 91.46 |
| Vascular Malformations and Hemangiomas | Lifetime | 877 | US 360 | 89.22 |
| Medicinal Plant Pharmacodynamics Research | Lifetime | 474 | US 57 | 77.95 |
| Soft tissue tumors and treatment | Lifetime | 530 | US 218 | 76.19 |
| Viral-associated cancers and disorders | 2021-2025 | 18 | US 7 | 98.51 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 78 | US 40 | 99.07 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 95 | US 48 | 98.74 |
| Acute Myeloid Leukemia Research | 2021-2025 | 240 | US 136 | 97.85 |
| CNS Lymphoma Diagnosis and Treatment | 2021-2025 | 69 | US 34 | 95.49 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 584 | US 276 | 91.73 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 205 | US 76 | 91.32 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 291 | US 123 | 88.79 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 702 | US 289 | 86.08 |
| Histiocytic Disorders and Treatments | 2021-2025 | 112 | US 51 | 80.61 |
| T-cell and Retrovirus Studies | 2021-2025 | 385 | US 85 | 75.38 |
| Parvovirus B19 Infection Studies | 2021-2025 | 503 | US 138 | 66.17 |
| Vascular Tumors and Angiosarcomas | 2021-2025 | 857 | US 272 | 55.21 |
| Lymphadenopathy Diagnosis and Analysis | 2021-2025 | 134 | US 32 | 27.55 |